X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (460) 460
Publication (38) 38
Newspaper Article (34) 34
Newsletter (30) 30
Book Chapter (15) 15
Book Review (14) 14
Magazine Article (5) 5
Conference Proceeding (1) 1
Dissertation (1) 1
Reference (1) 1
Trade Publication Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
belimumab (534) 534
systemic lupus erythematosus (306) 306
index medicus (251) 251
humans (233) 233
lupus (210) 210
rituximab (164) 164
rheumatology (157) 157
lupus erythematosus, systemic - drug therapy (138) 138
b-lymphocyte stimulator (106) 106
female (90) 90
double-blind (89) 89
monoclonal-antibody (88) 88
disease-activity (86) 86
drug therapy (81) 81
treatment outcome (78) 78
safety (76) 76
adult (71) 71
antibodies, monoclonal, humanized - therapeutic use (71) 71
immunosuppressive agents - therapeutic use (71) 71
lupus erythematosus, systemic - immunology (69) 69
efficacy (68) 68
male (68) 68
systemic-lupus-erythematosus (63) 63
pharmacology & pharmacy (62) 62
care and treatment (59) 59
nephritis (58) 58
immunology (57) 57
antibodies, monoclonal - therapeutic use (56) 56
b cells (56) 56
animals (55) 55
autoimmune diseases (54) 54
clinical trials (54) 54
middle aged (52) 52
research (50) 50
b-lymphocytes - immunology (46) 46
baff (46) 46
blys (46) 46
autoantibodies (45) 45
health aspects (45) 45
sle (44) 44
medical research (43) 43
autoimmunity (42) 42
disease (42) 42
rheumatoid-arthritis (41) 41
arthritis (39) 39
b-cell activating factor - antagonists & inhibitors (38) 38
antibodies, monoclonal, humanized (37) 37
dosage and administration (37) 37
immunotherapy (37) 37
medicine, experimental (36) 36
severity of illness index (36) 36
skin and connective tissue diseases (36) 36
medicine & public health (34) 34
lupus nephritis (32) 32
therapy (32) 32
atacicept (31) 31
analysis (30) 30
biologics (30) 30
drug approval (30) 30
internal medicine (30) 30
monoclonal antibodies (30) 30
mortality (29) 29
abatacept (28) 28
pathogenesis (28) 28
treatment (28) 28
classification (27) 27
medicine, general & internal (27) 27
patients (27) 27
antibodies, monoclonal, humanized - administration & dosage (26) 26
lymphocytes (26) 26
abridged index medicus (25) 25
antibodies, monoclonal, humanized - adverse effects (25) 25
corticosteroids (25) 25
rheumatoid arthritis (25) 25
clinical trials as topic (24) 24
immunologic factors - therapeutic use (24) 24
young adult (24) 24
pharmaceutical industry (23) 23
autoimmune-disease (22) 22
erythematosus (22) 22
immunosuppressive agents - administration & dosage (22) 22
reports (22) 22
antibodies, monoclonal - adverse effects (21) 21
b-cell activating factor - immunology (21) 21
epratuzumab (21) 21
immunosuppressive agents (21) 21
mycophenolate-mofetil (21) 21
phase-iii (21) 21
b-lymphocytes - drug effects (20) 20
immune system diseases (20) 20
immunosuppressive agents - adverse effects (20) 20
medicine (20) 20
product development (20) 20
studies (20) 20
usage (20) 20
biotechnology & applied microbiology (19) 19
medicine, research & experimental (19) 19
necrosis-factor family (19) 19
randomized controlled trials as topic (19) 19
chronic conditions (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (499) 499
German (15) 15
Russian (13) 13
Spanish (11) 11
French (6) 6
Japanese (3) 3
Polish (2) 2
Portuguese (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annales de Dermatologie et de Venereologie, ISSN 0151-9638, 01/2018, Volume 145, Issue 1, pp. 5 - 12
Background: Belimumab (an anti-BLyS monoclonal antibody) was recently approved for the treatment of systemic lupus erythematosus (SLE). The aim of the study... 
Belimumab | Lupus erythematosus
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 09/2017, Volume 74, Issue 17, p. 1296
Journal Article
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 11/2017, Volume 16, Issue 11, pp. 1119 - 1124
Biologic therapy is still limited in lupus, where chronic steroid exposure and wide-spectrum immunosuppression are major triggers of organ damage. In this... 
Treat-to-target | Individualized therapies | Biologics | Belimumab | Outcome measure | 5 EUROPEAN COUNTRIES | MONOCLONAL-ANTIBODY | IMMUNOLOGY | RITUXIMAB | INTERNATIONAL TASK-FORCE | CLINICAL-TRIALS | BELIMUMAB USE | TO-TARGET | NEPHRITIS | CAUCASIAN PATIENTS | OUTCOMES | Lupus | Immunotherapy | Systemic lupus erythematosus
Journal Article
Arthritis and Rheumatology, ISSN 2326-5191, 02/2018, Volume 70, Issue 2, pp. 266 - 276
Objective. To evaluate the efficacy and safety of atacicept, an antagonist of B lymphocyte stimulator/APRIL-mediated B cell activation, in patients with... 
B-LYMPHOCYTE STIMULATOR | RHEUMATOID-ARTHRITIS | MORTALITY | BELIMUMAB | REVISED CRITERIA | CLASSIFICATION | COHORT | APRIL LEVELS | RHEUMATOLOGY | DISEASE-ACTIVITY | CUTTING EDGE
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2019, Volume 78, Issue 11, pp. e119 - e119
Journal Article
Israel Medical Association Journal, ISSN 1565-1088, 09/2017, Volume 19, Issue 9, pp. 576 - 580
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9767, pp. 721 - 731
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 12/2019, Volume 139, Issue 12, pp. 2477 - 2487
Antibodies are key to cutaneous host defense and inflammation. Despite their importance, the mechanisms by which skin antibodies are sustained are poorly... 
B-LYMPHOCYTE STIMULATOR | SYSTEMIC-LUPUS-ERYTHEMATOSUS | IMMUNOGLOBULIN-A | BELIMUMAB | PHASE-III | DISEASE | DOUBLE-BLIND | INNATE | ANTIBODY | NATURAL IGM | DERMATOLOGY
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 06/2019, Volume 48, Issue 6, p. 1146
Systemic lupus erythematosus (SLE) is a representative autoimmune disease characterized by multiple organ manifestations but is molecularly and genetically... 
Lupus | Medical colleges | Psoriasis | Belimumab | Genetic aspects | Arthritis | College teachers | Drug therapy | T cells
Journal Article
Revue de Medecine Interne, ISSN 0248-8663, 04/2019, Volume 40, Issue 4, pp. 207 - 210
Journal Article
Biomedical Research (India), ISSN 0970-938X, 2018, Volume 29, Issue 16, pp. 3233 - 3238
Journal Article
Nature Reviews Rheumatology, ISSN 1759-4790, 2019, Volume 15, Issue 3, pp. 126 - 126
Journal Article
Lupus, ISSN 0961-2033, 9/2017, Volume 26, Issue 10, pp. 1123 - 1124
Journal Article
Nature Reviews Rheumatology, ISSN 1759-4790, 04/2016, Volume 12, Issue 4, pp. 194 - 194
Journal Article
BioDrugs, ISSN 1173-8804, 2011, Volume 25, Issue 3, pp. 203 - 205
Speaking for the inThought Expert Discussion Series in February, Dr George Tsokos mirrored the opinion of many lupus thought leaders: Human Genome Sciences... 
Systemic-lupus-erythematosus | Belimumab
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.